Diagnostics group adds $21M in second VC round

The UK's Abingworth led the second round for Primera Biosystems, helping pull in $21 million for the molecular diagnostics company. InterWest Partners joined with Malaysian Technology Development, MPM Capital, Burrill & Co. and the Invus Group in the round. Primera gained $11 million in its first round two years ago and has been developing new technology related to gene expression, DNA/RNA analysis, micro RNA analysis, mutation analysis and methylated DNA analysis.

- see Primera's release on the round
- here's the report on the round from MassHighTech

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.